Faith E. Davies, MD, NYU Langone's Perlmutter Cancer Center

Articles

Dr Davies on Addressing Global Gaps in Multiple Myeloma Care

November 22nd 2023

Faith E. Davies, MD, discusses strategies for rectifying global gaps and addressing unmet needs in multiple myeloma care.

Dr Davies on Challenges Experienced When Treating Patients With Multiple Myeloma

October 3rd 2023

Faith E. Davies, MD, discusses challenges experienced by hematologist-oncologists and specialist nurses when treating patients with multiple myeloma.

Holistic and Multidisciplinary Approaches to Multiple Myeloma Management

September 25th 2023

Closing out their program on multiple myeloma, expert panelists consider the role of holistic and multidisciplinary care when managing patients within the current paradigm.

Impact of Clinical Trials on the Management of Multiple Myeloma

September 25th 2023

Continuing its discussion on clinical trials in multiple myeloma, the panel emphasizes the impact that data may have on the real-world treatment landscape.

Importance of Clinical Trial Enrollment in Multiple Myeloma

September 18th 2023

Key opinion leaders in multiple myeloma management elucidate the value of clinical trials and share enthusiasm for improving enrollment when possible.

Multiple Myeloma: Regulatory Aspects of Treatment Development and Approval

September 18th 2023

A focused discussion on the regulatory aspects of drug testing and approval, globally, with respect to the setting of multiple myeloma management.

Educating Patients on Treatment Options for Multiple Myeloma

September 11th 2023

Expert panelists consider best methods in educating patients on their options for therapy following a diagnosis of multiple myeloma.

Treatment for Newly Diagnosed Multiple Myeloma: Addressing Disparities in Care

September 11th 2023

Comprehensive insight to disparities that may impact a patient’s access to therapy for multiple myeloma and how these may be overcome.

Treatment Considerations for Patients with Newly Diagnosed Multiple Myeloma

September 4th 2023

Panelists share a brief discussion on the current treatment armamentarium available to patients with newly diagnosed multiple myeloma.

Role of Diagnostic Testing in Patients with Multiple Myeloma

September 4th 2023

Experts in multiple myeloma management consider essential tests that aid in the diagnosis and treatment of newly presenting patients.

Educating on Multiple Myeloma: Patient and Physician Resources

August 21st 2023

Shared insight from key opinion leaders on educational resources made available to physicians and patients, respectively, regarding multiple myeloma management.

Multiple Myeloma: Challenges in Diagnosis and Role of Multidisciplinary Care

August 21st 2023

Opening its discussion on key unmet needs in multiple myeloma management, a panel of experts discuss key challenges faced when diagnosing patients with multiple myeloma and review the impact of having a multidisciplinary care team.

Dr. Davies on Isatuximab-Based Combinations in Relapsed/Refractory Multiple Myeloma

July 6th 2021

Faith Davies, MD, discusses the approval of isatuximab-irfc-based combinations for patients with relapsed/refractory multiple myeloma.

Dr. Davies on the Next Steps for CAR T-Cell Therapy in Relapsed/Refractory Myeloma

July 1st 2021

Faith E. Davies, MD, discusses the next steps for CAR T-cell therapy in the treatment of patients with relapsed/refractory multiple myeloma.

Dr. Davies on Future Research Directions With Isatuximab in Multiple Myeloma

June 16th 2021

Faith Davies, MD, discusses future research directions with isatuximab in the treatment of patients with multiple myeloma.

Dr. Davies on Key Considerations for Early-Relapse Multiple Myeloma

June 3rd 2021

Faith Davies, MD, discusses key considerations for developing a treatment strategy for patients with early-relapse multiple myeloma.

Dr. Davies on Personalizing Treatment in Relapsed/Refractory Myeloma

June 9th 2020

Faith E. Davies, MD, shares advice on how to best treat patients with relapsed/refractory multiple myeloma.

Dr. Davies on Research Efforts in Lenalidomide-Refractory Myeloma

April 21st 2020

Faith E. Davies, MD, discusses the research being done in patients with multiple myeloma who are refractory to lenalidomide.

Dr. Davies on the Use of Carfilzomib in Multiple Myeloma

April 14th 2020

Faith E. Davies, MD, discusses the dosing of carfilzomib in the treatment of patients with multiple myeloma.

Dr. Davies on Promise of Venetoclax in Relapsed/Refractory Myeloma

April 13th 2020

Faith E. Davies, MD, discusses the use of venetoclax as a precision medicine approach in patients with relapsed/refractory multiple myeloma.